Linking the Mycobacterium ulcerans environment to Buruli ulcer disease: Progress and challenges

被引:14
|
作者
Dhungel, Laxmi [1 ]
Benbow, Mark Eric [2 ]
Jordan, Heather Rose [1 ]
机构
[1] Mississippi State Univ, Dept Biol Sci, 295 Lee Blvd, Starkville, MS USA
[2] Michigan State Univ, Dept Entomol, Dept Osteopath Med, 243 Nat Sci Bldg,288 Farm Lane, E Lansing, MI 48824 USA
基金
美国国家科学基金会;
关键词
Mycobacterium ulcerans; Buruli ulcer; Transmission; One-health; REAL-TIME PCR; AQUATIC INSECTS; TRANSMISSION; INFECTION; ASSOCIATION; EVOLUTION; OUTBREAK; VECTOR; GROWTH; GHANA;
D O I
10.1016/j.onehlt.2021.100311
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Buruli ulcer (BU), the second most common mycobacterial disease in West Africa, is a necrotizing skin disease that can lead to high morbidity in affected patients. The disease is caused by Mycobacterium ulcerans (MU), whose major virulence factor is mycolactone. Although early infection can be treated with antibiotics, an effective preventative strategy is challenging due to unknown reservoir(s) and unresolved mode(s) of transmission. Further, disease occurrence in remote locations with limited access to health facilities further complicates disease burden and associated costs. We discuss here MU transmission hypotheses and investigations into environmental reservoirs and discuss successes and challenges of studying MU and Buruli ulcer across human, animal, and environmental interfaces. We argue that a One Health approach is needed to advance the understanding of MU transmission and designing management scenarios that prevent and respond to epidemics. Although previous work has provided significant insights into risk factors, epidemiology and clinical perspectives of disease, understanding the bacterial ecology, environmental niches and role of mycolactone in natural environments and during infection of the human host remains equally important to better understanding and preventing this mysterious disease.
引用
下载
收藏
页数:9
相关论文
共 50 条
  • [41] Buruli Ulcer Disease in Travelers and Differentiation of Mycobacterium ulcerans Strains from Northern Australia
    Lavender, Caroline J.
    Globan, Maria
    Johnson, Paul D. R.
    Charles, Patrick G. P.
    Jenkin, Grant A.
    Ghosh, Niladri
    Clark, Benjamin M.
    Martinello, Marianne
    Fyfe, Janet A. M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (11) : 3717 - 3721
  • [42] Mycobacterium ulcerans Disease (Buruli Ulcer) in Mali: A New Potential African Endemic Country
    Bessis, Didier
    Kempf, Marie
    Marsollier, Laurent
    ACTA DERMATO-VENEREOLOGICA, 2015, 95 (04) : 489 - 490
  • [43] Decrease in Mycobacterium ulcerans disease (Buruli ulcer) in the Lalo District of Benin (West Africa)
    Anagonou, Esai Gimatal
    Johnson, Roch Christian
    Barogui, Yves Thierry
    Sopoh, Ghislain Emmanuel
    Ayelo, Gilbert Adjimon
    Wadagni, Akpeedje Carolle
    Houezo, Jean Gabin
    Agossadou, Didier Codjo
    Boko, Michel
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [44] Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease
    Dobos, KM
    Spotts, EA
    Marston, BJ
    Horsburgh, CR
    King, CH
    EMERGING INFECTIOUS DISEASES, 2000, 6 (02) : 158 - 164
  • [45] A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans
    Zingue, Dezemon
    Panda, Arup
    Drancourt, Michel
    SCIENTIFIC REPORTS, 2018, 8
  • [46] Aquatic insects and Mycobacterium ulcerans:: An association relevant to buruli ulcer control?
    Silva, Manuel T.
    Portaels, Francoise
    Pedrosa, Jorge
    PLOS MEDICINE, 2007, 4 (02) : 229 - 231
  • [47] Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
    Bratschi, Martin W.
    Ruf, Marie-Therese
    Andreoli, Arianna
    Minyem, Jacques C.
    Kerber, Sarah
    Wantong, Fide Le G.
    Pritchard, James
    Chakwera, Victoria
    Beuret, Christian
    Wittwer, Matthias
    Noumen, Djeunga
    Schuerch, Nadia
    Book, Alphonse Um
    Pluschke, Gerd
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (03):
  • [48] Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer)
    Portaels, F
    Aguiar, J
    Debacker, M
    Steunou, C
    Zinsou, C
    Guédénon, A
    Meyers, WM
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (06) : 1389 - 1391
  • [49] Serum cytokine profile during Mycobacterium ulcerans infection (Buruli ulcer)
    Zavattaro, Elisa
    Mesturini, Riccardo
    Dossou, Ange
    Melensi, Matteo
    Johnson, Roch Christian
    Sopoh, Ghislain
    Dianzani, Umberto
    Leigheb, Giorgio
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (11) : 1297 - 1302
  • [50] Dynamics of the Cytokine Response to Mycobacterium ulcerans during Antibiotic Treatment for M-ulcerans Disease (Buruli Ulcer) in Humans
    Sarfo, F. S.
    Phillips, R. O.
    Ampadu, E.
    Sarpong, F.
    Adentwe, E.
    Wansbrough-Jones, M.
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (01) : 61 - 65